Passage of the prototypic arenavirus lymphocytic choriomenigitis virus (LCMV) in cultured cells in the presence of the mutagenic agent 5-fluorouracil (FU) resulted in efficient and systematic virus extinction under conditions that did not significantly affect cell survival. FU-mediated extinction of LCMV was associated with 3.6-to 10-fold increases in the mutation frequencies for the three viral genes examined, but with only very modest effects on virus replication and transcription during a single round of infection. Likewise, FU did not affect expression of a LCMV minigenome. In contrast, the well documented antiviral effect of ribavirin against LCMV was not associated with significant increases in virus mutation frequencies, but rather with a dramatic inhibition of both viral RNA synthesis and LCMV minigenome expression. Mutagen induced viral extinction has been recently reported for positive strand RNA viruses polio and foot-andmouth disease, and the lentivirus HIV-1. Our findings indicate that lethal mutagenesis can be effective also against LCMV, a negative strand RNA virus. Moreover, FU treatment prevented the establishment of LCMV persistent infection in mice deficient in B and T cells, suggesting the feasibility in vivo of lethal mutagenesis as a novel antiviral strategy.
Introduction
Riboviruses usually exhibit extensive genetic variability and potential for rapid evolution (Holland et al., 1982; Holland, 1992; Domingo et al., 2001) . The molecular basis for this variation is extremely high mutation frequencies per average site in RNA virus genomes (Drake and Holland, 1999) . This in turn is facilitated by the error-prone nature of the RNA-dependent RNA polymerases (RdRp), enzymes for which efficient proofreading activity has not been yet demonstrated (Steinhauer et al., 1992) . Such high mutation frequencies, combined with small genome sizes, short replication cycles and high fecundity, dictate that RNA viruses replicate and evolve as dynamic complex mutant distributions termed quasispecies (Eigen and Biebricher, 1988) . Error-prone replication predicts that for a given genomic complexity there is a critical copying fidelity below which information can no longer be maintained. Any further decrease in fidelity would result in the so-called error catastrophe (Swetina and Schuster, 1982; Schuster and Stadler, 1999) , which is accompanied by total loss of information associated with the RNA genome sequence and thereby virus extinction. Studies on the effect of chemical mutagenesis on mutation frequencies of poliovirus (PV) and vesicular stomatitis virus (VSV) showed that mutation frequencies at defined single-nucleotide sites could be increased only very modestly (1.1-to 2.8-fold) even with losses in virus survival higher than 99% (Holland et al., 1990) . These results, together with the generally observed high mutation rates during RNA genome replication (Drake and Holland, 1999) , provide strong support for the view that riboviruses replicate very near the threshold for error catastrophe. Near the error threshold virus viability is maintained for a substantial percentage of progeny, while generation of an enormous spectrum of mutants is ensured, thus facilitating virus adaptation. The composition of these quasispecies is determined by competitive fitness under prevailing conditions (Eigen and Biebricher, 1988) . This allows riboviruses to maintain themselves stably in a given ecological niche, while retaining the ability to adapt quickly to changing conditions.
The genetic structure of quasispecies intrinsic to riboviruses can impact anti-viral therapies significantly. Thus, even before exposure to a drug, the ensemble of related genome species within the viral quasispecies may already contain drug-resistant variants, or mutants that are one mutation away from becoming drug resistant. This situation also applies to the use of antiviral immune molecules and cells, as illustrated by the frequent emergence of variants resistant to neutralizing antibodies and cytotoxic T cells. On the other hand, proximity to error catastrophe during ribovirus replication raises the intriguing possibility of using mutagenic agents to drive RNA viruses into error catastrophe, thus causing virus extinction. Recent findings with the picornaviruses foot-and-mouth disease (Sierra et al., 2000; Pariente et al., 2001) and poliovirus (Crotty et al., 2000; Crotty et al., 2001) , as well as with the flavivirus GB virus (Lanford et al., 2001) and the lentivirus HIV-1 (Loeb et al., 1999) , have provided strong support for the feasibility of this novel antiviral approach which has been referred to as lethal mutagenesis (Loeb et al., 1999) .
In this paper we examine whether an antiviral strategy based on the concept of lethal mutagenesis can also be efficiently used against the prototypic arenavirus lymphocytic choriomeningitis virus (LCMV). Arenaviruses merit significant attention both as experimental models to study virus-host interactions (Buchmeier and Zajac, 1999) and as clinically important human pathogens, including hemorrhagic fever agents such as Lassa virus (Peters et al., 1996; McCormick and Fisher-Hoch, 2002; Peters, 2002) . LCMV is an enveloped virus with a bisegmented negative strand RNA genome. Its molecular biology has been recently reviewed (Salvato, 1993; Southern, 1996; Meyer et al., 2002) . The two genomic RNA segments are designated L and S, and have approximate sizes of 7.2 and 3.4 kb, respectively. The S RNA directs synthesis of the nucleoprotein, NP (ca 63 kDa), and the two virion glycoproteins, GP-1 and GP-2, that are derived by posttranslational cleavage of a precursor polypeptide, GP-C. GP-1 and GP-2 make up the spikes on the virion envelope, and mediate virus interaction with the host cell surface receptor (Cao et al., 1998; Kunz et al., 2002) . The L RNA segment codes for the virus RNAdependent RNA polymerase (RdRp) (L, ca 200 kDa) ) and a small (11 kDa) RING finger protein called Z Salvato et al., 1992) whose roles in the virus life cycle are poorly understood (Salvato et al., 1992; Campbell Dwyer et al., 2000; Cornu and de la Torre, 2001; Djavani et al., 2001; Kentsis et al., 2001) . The NP and viral polymerase are complexed with the genomic viral RNA to form ribonucleoprotein (RNP) complexes, which are active in virus transcription and replication (Fuller-Pace and Southern, 1989; Cornu and de la Torre, 2001) .
We show that serial LCMV passages in the presence of the mutagenic agent 5-fluorouracil (FU), at a concentration compatible with good cell survival (Ͼ80%), resulted in efficient and systematic virus extinction. FU-mediated extinction of LCMV was associated with increases in the mutation frequencies for the three viral genes examined: NP (3.6-fold), GP (10.0-fold), and L-polymerase (5.9-fold). The concentration of FU (200 g/ml) used to cause LCMV extinction caused only modest decreases in virus replication and transcription during a single round of infection, and did not affect expression of a LCMV minigenome. In contrast, and contrary to the findings described for PV, the antiviral activity of ribavirin (Rib) against LCMV was not associated with significant increases in the mutation frequencies of the same LCMV genes, but rather with a dramatic inhibition of both viral RNA synthesis and LCMV minigenome expression. We also show that FU treatment prevented the establishment of LCMV persistent infection in mice deficient in B and T cells (RAG2Ϫ/Ϫ) (Alt et al., 1992; Shinkai et al., 1993) , suggesting the feasibility in vivo of lethal mutagenesis as a novel antiviral strategy.
Results

Effect of FU and Rib on LCMV multiplication during a single round of infection
We first examined the effect of increasing amounts of FU and Rib on the viability of BHK21 cells ( Fig. 1 ). For this, we treated BHK-21 cells with increasing concentrations of FU or Rib, and at the indicated post-exposure times cell viability was determined by staining with the supravital dye neutral red and exclusion of the dye trypan blue. Cells treated with FU concentrations of 50 or 200 g/ml exhibited more than 90 and 80%, respectively, viability after 48 h treatment. Increasing the concentration of FU to 800 g/l resulted in significant levels (more than 30%) of cell death. Consistent with a previously reported low cell toxicity of Rib (Huggins et al., 1984) , all the Rib concentrations we tested had only minimal effects on cell survival after 48 h treatment ( Fig. 1) .
We then assessed the effect of the presence of increasing amounts of FU or Rib during a single-step LCMV growth. BHK-21 cells were treated with the indicated concentrations of FU or Rib and subsequently infected with LCMV ARM (MOL of 3). At indicated times, titers of infectious virus in the culture cell media were determined by plaque assay. Increasing concentrations of FU and Rib correlated with decreases in virus production ( Fig. 2 ). For the same set of samples we also determined levels of virus replication and transcription at 24 h p.i. For this, total cellular RNA was isolated and analyzed by Northern blot using a LCMV-NP probe to detect genome S RNA (replication) and NP mRNA (transcription). Hybridization signals were quantified by PhosphorImager and normalized with respect to those found in untreated cells (defined as 100%). As with virus titers, levels of LCMV replication and transcription were increasingly reduced with increases in drug concentrations ( Fig. 3 ). At the concentrations tested, Rib had a more severe effect than FU on viral RNA synthesis. Thus, we could detect LCMV replication and transcription at the highest (800 g/ml) FU dose used, whereas in cells treated with 200 or 400 M Rib levels of LCMV replication and transcription were below the sensitivity of our Northern blot assay.
The reduction of about 100-fold in virus production in cells treated with 200 g/ml of FU was associated with about a five-fold reduction in RNA synthesis. In contrast, a similar reduction in virus production in cells treated with 200 M Rib was accompanied by undetectable levels of viral RNA synthesis (compare Figs. 2 and 3 ). This finding suggested that FU and Rib were likely exerting their antiviral actions against LCMV via different mechanisms. Consistent with this view, FU and Rib differed also in their ability to inhibit the expression of a LCMV minigenome (MG) mediated by plasmid-supplied viral transacting factors ( Fig. 4) . At the drug concentrations that caused a 100-fold reduction in virus production, FU caused only a 10% inhibition of LCMV MG expression, whereas Rib completely abrogated MG expression. Western Blot analysis showed that expression levels of plasmid supplied LCMV trans-acting factors NP and L proteins were similar in FU (200 g/ml) and Rib (200 M) treated cells, and only slightly reduced compared to those seen in drug-untreated control samples (data not shown).
Effect of FU and Rib on serial passages of LCMV
For these studies we used FU and Rib at concentrations of 200 g/ml and 400 M, respectively. These drug concentrations were selected based on their effects on cell survival ( Fig. 1) and LCMV multiplication during one-step growth (Figs. 2 and 3). Drug effects on LCMV multiplication were monitored by determining virus titers in the supernatant of each serial passage and intracellular levels of virus RNA. Production of infectious virus was not detected after the first and second serial passage in the presence of Rib or FU, respectively ( Fig. 5A ). Likewise, after the second (Rib) and third (FU) passage in the presence of drugs, intracellular LCMV RNA was undetectable by RT-PCR, (Fig. 5B ). These findings were consistent with a well documented antiviral activity of Rib against arenaviruses, and raised the possibility that treatment with FU could also cause systematic extinction of LCMV under our cell culture conditions. To test this hypothesis, we did ten independent replicas of serial passages of LCMV in the absence or presence of FU (200 g/ml); the results were similar among the ten independent replicas (Fig. 6A, B ). In the absence of FU, both infectious virus and viral RNA were readily detected and virus titers and viral RNA did not vary significantly among passages. In contrast, in the presence of FU infectious virus was not detected after the second passage, and after the third passage intracellular LCMV RNA was undetectable by RT-PCR. Removal of FU after the third passage and subsequent passages in the absence of drug did not allow recovery of infectious virus in the supernatant (Fig. 6A ) or detection of intracellular viral RNA ( Fig. 6C ). Moreover, inoculation (i.v.) of IFNa/bR-KO mice (N ϭ 5) with 0.5 ml of the supernatant of FU-P3 did not result in a productive infection, whereas all IFNa/bR-KO mice (N ϭ 5) inoculated with 0.5 ml of medium containing 1 PFU of LCMV ARM developed viremia (range 7 ϫ 10 5 to 2 ϫ 10 6 PFU/ml in serum) (data not shown). This assay was done based on our observation that IFNa/bR-KO mice provide us with a readout for infectious LCMV that is about 100-fold more sensitive than the standard plaque assay on Vero cells.
Effect of FU and Rib on LCMV mutation frequencies
The mutagenic action of FU on riboviruses is well documented (Pringle, 1970; Holland et al., 1990; Sierra et al., Fig. 5 . Serial passages of LCMV ARM in the presence of FU (200 g/ml) or Rib (400 M). Supernatants of each indicated passage in the presence of FU or Rib as well as untreated control cells were assayed for infectious LCMV by plaque assay (A). Total cellular RNA was isolated from the indicated passages in the presence of FU (B), or Rib (C), and analyzed by RT-PCR. The RT reaction was primed with random hexamers and the resulting cDNAs were amplified with specific primers for the virus NP or the cellular housekeeping gene GAPDH. At 24 h post-transfection, cell lysates were prepared for CAT assay. Equal amounts of protein from each lysate were used for the CAT assay. Amount of cell extract and reaction time were adjusted to provide linear conditions of enzyme activity (less than 40 % of Cm conversion). CAT activity in each sample was normalized with respect to that associated with lysates of drug-untreated cells (100%). Shown are the average of three independent experiments. Standard deviations (not shown) never exceeded 5%.
2000; Pariente et al., 2001) , and more recent studies with PV have shown that Rib also can have a mutagenic activity (Crotty et al., 2001) . Evidence indicates that the mutagenic action of both FU and Rib are responsible for dramatic losses in the virus infectivity upon treatment with these drugs, a process that has been called lethal mutagenesis (Loeb et al., 1999) . We therefore examined whether lethal mutagenesis was also at the root of FU-and Rib-mediated elimination of LCMV in cultured cells. With this aim we determined the mutation frequency values in preextinction viral populations (FU-P2 and Rib-P1), and compared these values with those of an untreated control virus population (P5) ( Table 1) .
We used RT-PCR procedures to amplify LCMV genomic regions of the NP, GP and L viral genes. The size of the region amplified for each of the three genes was similar (ca. 500 bp). For each sample and gene region we sequenced a similar number of clones derived from three independent RT-PCR reactions. This approach was followed to minimized bias due to the possible amplification of mutations introduced by the RT-PCR procedure. To determine the mutation frequencies in the NP, GP and L regions analyzed, we counted only once each different mutation found within each virus population examined.
The untreated control P5 virus population exhibited mutation frequencies in the range of 2.6 ϫ 10 Ϫ4 to 5.5 ϫ 10 Ϫ4 mutations per nucleotide, compared to the parental LCMV ARM used for these studies. These values are consistent with previous findings about genetic heterogeneity of LCMV (Sevilla et al., 2002) , and other arenaviruses (Bowen et al., 1997; Bowen et al., 2000; Sevilla et al., 2002) , and also within the range commonly observed for riboviruses . Compared to untreated control P5, the Rib-P1 preextinction LCMV population did not exhibit significant increases in mutation frequencies for any of the three genomic regions examined. In contrast, the FU-P2 preextinction population had increases in mutation frequencies ranging from 3.6 (NP gene) to 10.0 (GP gene). Moreover, for the three genomic regions analyzed, FU-P2 had increased Shannon entropies (Table 1) , which is a measure of the different molecular species present within the mutant spectrum of the population (Volkenstein, 1994) . Thus, the complexity of the mutant spectrum was increased in FU-P2 compared to Rib-1 and P5 populations. Among the 49 different nucleotide substitutions found in FU-P2, the two more abundant were transitions A to G (18/49, 36.7%) and U to C (16/49, 32.6%) ( Table 2) , which have been associated with the mutagenic action of FU (Yu et al., 1993) . We observed a nonuniform distribution of mutations accross the LCMV genome regions examined. Thus, GP exhibited 1.7 and 2.8 higher increases in mutation frequencies than L and NP, respectively, but the three genomic regions examined in FU-P2 had a similar distribution of synonymous vs nonsynonymous mutations. Synonymous substitutions represented 23.8% (5/16), 21.4% (3/11) and 28.5% (4/10) of the mutations found in GP, NP and L, respectively. These frequencies of synonymous substitutions are comparable to what would be expected on a random basis (ca. 21%).
Effect of FU on LCMV infection of RAG2Ϫ/Ϫ mice
The high efficiency with which FU mediated extinction of LCMV in cultured cells led us to investigate whether FU-induced lethal mutagenesis could be observed during LCMV infection of its natural host the mouse. In the adult immunocompetent mouse LCMV infection is controlled by a vigorous T-cell response that eventually results in viral clearance from blood and tissues. This host immune response would be a confounding factor when trying to assess Fig. 6 . Systematic and rapid extinction of LCMV by FU treatment. Shown are three representative cases of ten independent replicas of LCMV serial passages in the presence of FU (200 g/ml) done as described Fig. 5 . LCMV titers were determined in supernatants of each passage (A). Likewise, for each passage the presence of intracellular LCMV RNA was determined by RT-PCR using specific primers to amplify a segment of the NP gene (about 500 bp), and as a control a segment (about 200 bp) of the cellular housekeeping GAPDH gene (B). In a set (five) of additional replicas of serial passages, FU was removed at P3 and subsequent passages (P4 to P7) were done in the absence of drug. Virus titers in supernatants of P4 to P7 (A, dotted lines), and intracellular LCMV RNA in P6 and P7 (C) of two of the five replicas were determined as described in sections A and B of this figure. the direct effect of FU on LCMV multiplication. To overcome this limitation we used RAG2-KO mice, which lack mature T and B cells due to a deletion of recombination activating gene-2 (Alt et al., 1992; Shinkai et al., 1993) . LCMV infection of these genetically altered mice results in the establishment of a persistent infection where infectious virus can be readily detected in blood and tissues for long periods of time.
We infected RAG2-KO mice with LCMV ARM (100 PFU/mouse, i.p.) and treated them either with FU or PBS found in each genomic region analyzed (NP, GP and L) and its percent with respect to the total number of mutations found in the the three genomic regions of the corresponding population.
d Determined by comparing sequences determined after serial passages under indicated conditions with that of the parental ARM reference sequence that was not subjected to serial passages. e Determined with respect to the untreated control population. f The normalized Shannon entropy was calculated as -⌺(p i ϫ lnp i )/lnN in which p i is the frequency of each sequence in the quasispecies and N is the total number of sequences compared. Table 2 Types of mutations in the mutant spectrum of LCMV aRMS control (CNT-P5) and pre-extinction (FU-P2 and Rib-P1) populations Total  2  3  2  21  14  14  2  3  3  Transitions  1  2  2  20  12  14  2  3  3  Transversions  1  1  0  1  2  0  0  0  0  Synonymous  1  2  0  5  3  4  1  2  1  Non-synonymous  1  1  2  16  11  10  1  1  2 Note. Mutations were determined by comparison of serially passaged populations with the parental ARM reference sequence.
following the protocol described in Materials and Methods. At 12 days p.i. serum and spleen tissue were collected and analyzed for virus titers and presence of viral RNA by RT-PCR. The four mice treated with PBS had high titers of LCMV in serum and spleen, whereas 3 out of 4 mice treated with FU did not have detectable levels of infectious virus in serum or spleen (Fig. 7) . The remaining FU-treated mouse had significant decreased virus titers in serum and spleen compared to PBS-treated control mice. Consistent with results of virus titers, RNA was detected in the spleen of the four mice treated with PBS, whereas among the FU-treated mice only the one positive for infectious virus was also positive for RNA in spleen. Thus, treatment of RAGϪ/Ϫ mice with FU was effective in preventing the establishment of a persistent infection with LCMV.
Discussion
Initial studies on the effect of chemical mutagenesis on mutation frequencies and viability of PV and VSV showed that mutation frequencies at defined single-nucleotide sites could be increased only very modestly (1.1-to 2.8-fold) even with losses in virus survival higher than 99% (Holland et al., 1990) . These results provided the first direct experimental evidence that riboviruses may replicate very near the threshold for error catastrophe, a critical error rate, predicted from theoretical studies, to set a limit for maintenance of genetic information (Swetina and Schuster, 1982; Eigen and Biebricher, 1988; Eigen, 2000) . More recent studies with HIV-1 (Loeb et al., 1999) , the picornaviruses FMDV (Sierra et al., 2000; Pariente et al., 2001) , and PV (Crotty et al., 2000; Crotty et al., 2001) , as well as GB virus B (Lanford et al., 2001) , have shown the feasibility of using mutagens as antiviral drugs against riboviruses. In the case of FMDV and HIV-1, treatment with mutagens led to virus extinction, which has been called lethal mutagenesis (Loeb et al., 1999; Sierra et al., 2000) . The use of this strategy to combat riboviruses in general would require its efficacy also against negative strand RNA viruses, whose basic replication strategy differs significantly from that of positive strand riboviruses and lentiviruses. Our results show that lethal mutagenesis is also effective in causing systematic extinction in cultured cells of LCMV, a negative strand RNA virus. Moreover, our findings also suggest that this novel antiviral approach may be feasible in vivo.
Consistent with previous reports (McKee et al., 1988; Huggins, 1989; de la Torre and Oldstone, 1992) , Rib (200 M) had a powerful inhibitory effect on LCMV multiplication. Recent studies with PV have led to the intriguing proposal that the antiviral activity of Rib is related to its mutagenic action on genome RNA during replication mediated by the virus RdRp (Crotty et al., 2000; Crotty et al., 2001) . This hypothesis would predict that Rib-mediated elimination of LCMV occurs also via lethal mutagenesis. However, our data show that the inhibitory effect of Rib on LCMV multiplication was not associated with a significant increase in mutation frequencies in the virus genome (Table  1) , but rather with the abrogation of RNA synthesis mediated by the LCMV polymerase (Figs 2, 3, and 4) . A number of different mechanisms have been proposed to account for the antiviral activity of Rib (Snell, 2001) . It is plausible that the prominent mechanism of action of Rib may vary for different types of viruses, and that while for PV its main antiviral effect is through enhanced mutagenesis, other mechanisms operate in the case of LCMV. Also, the isolation of Sindbis virus variants resistant to Rib (Scheidel et al., 1987; Scheidel and Stollar, 1991) suggests that lethal mutagenesis is unlikely to be the antiviral mechanism of Rib against this alphavirus.
FU is incorporated into RNA and has been shown to be mutagenic for a number of RNA viruses (Pringle, 1970; Holland et al., 1990; Sierra et al., 2000; Pariente et al., 2001) . In addition, low concentrations (1 g/ml) of FU has been shown to have a potent inhibitory effect on the replication of rinderpest virus (Ghosh et al., 1996) . Moreover, FU can also interfere with RNA processing and translation (Parker and Cheng, 1990) , which could affect expression of host cell factors required for virus multiplication. However, our results (Figs. 2 and 3) indicate that such effects, though they likely contribute, cannot account for the observed FUmediated extinction of LCMV. Our findings rather point to FU-enhanced mutagenesis of LCMV genome as the driving force of LCMV extinction (Table 1) . Consistent with the mutagenic action of FU (Parker and Cheng, 1990; Yu et al., 1993) , transitions (A to G and U to C) were the most abundant mutations found in FU-P2 preextinction population (Table 2) . We observed a nonuniform distribution of mutations across the three LCMV genome regions examined, suggesting that results based on the examination of only one genomic region could be misleading. However, the three genomic regions had a similar distribution of synon- ymous vs non-synonymous mutations ( Table 2) . We cannot rule out that one particular mutation could be the result of misincorporation during the RT-PCR amplification instead of spontaneous or mutagen induced. Nevertheless, control experiments have shown that under the experimental conditions we used for RT-PCR, the vast majority of the mutations detected corresponded to those present in the virus RNA (Najera et al., 1995; Sauder et al., 1996) .
Studies with FMDV have shown that low viral loads and low relative fitness favor viral extinction (Pariente et al., 2001) . Efficient extinction of FMDV required the combination of the mutagen FU with an antiviral drug (Pariente et al., 2001) . In contrast, FU alone was highly efficient in mediating rapid extinction of LCMV. At the present time we can only speculate about possible reasons for these differences. Features intrinsic to the replication machineries of FMDV and LCMV, or in general between positive and negative strand RNA viruses, could have contributed to these differences. Thus, for example, recombination is a very prevalent phenomenon among positive RNA-viruses and has been implicated in counteracting potentially deleterous mutations generated during error prone replication of riboviruses (Chao, 1990; Domingo and Holland, 1997) . In contrast, homologous recombination is an extremely rare event during replication of negative strand RNA viruses (Pringle and Parry, 1982) . As with other RdRp, the LCMV polymerase is likely to carry on several enzymatic processes associated with different functional domains, which can contribute to making L highly sensitive to mutational inactivation. The coding region of the LCMV RdRp represents more than 50% of the virus genome. Assuming a random distribution of mutations due to FU incorporation into the nascent chain during RNA replication, the sequence of the RdRp would be a main target of drug-induced mutagenesis. This can result in the rapid accumulation of defective polymerases with the consequent effect on virus viability. This can be further enhanced by the specific mutagenic activity of the drug used. For example within motif C of the LCMV L polymerase 21 out of 33 nucleotide positions are susceptible to FU-induced transitions during one single round of replication, with 17 of these 21 nucleotide substitutions resulting in predicted amino acid changes. Studies using reverse genetic approaches have shown that the majority of amino acid substitutions, including conservative ones, within motifs A and C result in a severely impaired, or totally inactive, LCMV polymerases. Similar considerations can be extended to other functional domains within the LCMV polymerase, which underscores how modest increases in mutation frequencies can have a dramatic impact on the virus biology.
The quasispecies model of RNA virus population predicts that entry into error catastrophe would be accompanied by a randomization of the virus genome sequence, which should be reflected by the accumulation of hypermutagenized RNA virus genomes. However, we did not detect hypermutagenized sequences among those derived from preextinction populations. This apparent discrepancy can be explained by considering that the prediction of the quasispecies model is based on the assumption that mutants generated during decreased copying fidelity of the system will have similar fitness. In contrast, in the context of the virus biology many of the mutations introduced into the replicating virus can result in non-viable genome sequences without the capability for amplification, and hence undetectable by current biochemical methods. In addition, mutations affecting primer binding sites used for RT-PCR can prevent amplification of a complete representation of mutant RNA molecules generated during drug-enhanced mutagenesis.
Results from different laboratories using different viral systems, including those presented here have provided strong support for using lethal mutagenesis as a novel antiviral strategy against riboviruses. These findings have raised the pressing question of whether this approach has some feasibility in vivo. FU treatment of RAG2Ϫ/Ϫ mice prevented the establishment of a LCMV persistent infection. The lack of T-and B-cell responses in these mice suggests a direct effect of FU on virus viability as the reason for preventing LCMV persistence. Certainly, LCMV infection of RAG2Ϫ/Ϫ mice is an experimental model that does not recreate the complex spectrum of host-ribovirus interactions, but our findings provide a first and necessary step to encourage future research aimed at exploring the potential of lethal mutagenesis to combat ribovirus infections and associated diseases. This approach will face a formidable challenge related to potential toxicity and undesirable clinical side effects associated with this therapy. However, considering the fast pace at which the field of nucleoside chemistry is progressing, it seems feasible in the near future to develop mutagenic nucleoside analogs that can be readily and specifically incorporated by the viral RdRp but with no or limited cell toxicity.
Materials and methods
Cells, viruses and infections
Baby hamster kidney cells (BHK-21) were grown in Dulbecco's modified minimal essential medium (DMEM) supplemented with heat inactivated (55°C for 30 min) 10% fetal calf serum (FCS), 2 mM L-glutamine, 1X tryptose phosphate broth (TPB), 1 mM sodium pyruvate and 0.5% glucose. Infections with lymphocytic choriomeningitis virus (LCMV) were done using a plaque-isolated clonal virus population of strain Armstrong (ARM). Procedures for infection of BHK-21 cells with LCMV in liquid medium and for virus titration in Vero cells using semisolid agar medium have been described (Teng et al., 1996) .
Knockout mice lacking the recombination activating gene-2 (RAG2-KO) (Alt et al., 1992; Shinkai et al., 1993) or the IFN a/b receptor (IFNa/bR-KO) (Muller et al., 1994) , were maintained in conditions consistent with the facility animal care regulation (AAALAC) throughout the course of investigation. All the studies were done with adult mice (6 -9 weeks old).
Mutagenic agents and mutagenic treatments
FU (Sigma) and Rib (gift from R. Robins) were dissolved in DMEM to yield stock solutions of 2.5 mg/ml and 10 mM, respectively. These solutions were sterilized by filtration (0.22 m membrane filter, Costar). Stock solutions were aliquoted, stored at Ϫ20°C and diluted as needed. RAG2Ϫ/Ϫ mice (males with average weight 22.5 g, range 22-24) were treated with 2 mg/Kg/day of FU given intraperitoneally (i.p.). This treatment follows a dosing regimen that simulated a chemotherapy protocol used for treatment of colon cancer (Lucchinetti et al., 1997) . Control mice were inoculated daily also i.p. with the same volume of the drug diluent, phosphate buffer saline (PBS). Mice were monitored for loss of weight daily. Under the experimental conditions used, FU-treated mice had less than 5% weight loss compared to PBS-treated control mice.
Analysis of LCMV RNA replication and transcription in infected cells
To determine levels of LCMV RNA during a single round of infection in the presence of FU or Rib, drug-treated and untreated control BHK-21 cells were infected with LCMV ARM5 at an MOL of 2. At 24 h p.i., RNA was isolated by using TRIreagent (Molecular Research Center Inc.) according to the supplier's protocol and equal amounts (5 g) analyzed by Northern blot hybridization as described using a 32 P-labeled double strand DNA NP probe (Teng et al., 1996; Cornu and de la Torre, 2001) . This probe detects both the S genomic RNA (replication) and the NP mRNA (transcription). Hybridization signals were quantified by phosphorimager. Intracellular levels of LCMV RNA in serial passages in the presence of FU or Rib were determined by RT-PCR. The RT reaction was primed with random hexamers and the resulting cDNAs were amplified by PCR using specific primers for the virus NP or for the cellular housekeeping gene GAPDH.
Analysis of LCMV minigenome expression
The analysis of LCMV minigenome expression was done essentially as described (Lee et al., 2000) . Briefly, BHK-21 cells treated with FU or Rib and untreated control cells were infected with vTF7.3 at an MOL of 3, and transfected with pLCMVSCAT2 (MG) (0.5 g), pCITE-NP (1.5 g), pGEM-L (0.1 g), and pTMI-GFP (0.1 g). Plasmid pLCMVSCAT2 directs intracellular T7-mediated synthesis of the LCMVSCAT2 minigenome in which the viral NP and GP ORF encoded by the S RNA have been replaced by an antisense (AS) copy of the chloramphenicol acetyltransferase (CAT) ORF. The CAT AS ORF is flanked by the 5Ј UTR-IGR and 3Ј UTR of the LCMV S RNA. Plasmid pTMI-GFP was included to assess the efficiency of transfection based on GFP expression, and to control for a possible effect of FU or Rib on T7 RNA polymerasemediated expression of plasmid supplied LCMV MG RNA and trans-acting factors NP and L. In all cases, the amount of DNA used in the transfections was normalized to 2.7 g/M6 well by using pTMI plasmid. Transfections were performed using Lipofectamine (Life Technologies). GFP expression was assessed by epifluorescence microscopy before harvesting the transfected cells. Cells were resuspended in 2 ml of phosphate buffered saline (PBS) and split in two equal aliquots. One aliquot was resuspended in 50 l 0.25 M Tris-HCl pH 7.5, and cell lysates were prepared and assayed for CAT activity (Lee et al., 2000) . The other aliquot was resuspended in lysis buffer (50 mM Tris-HCI pH 8, 6.25 mM EDTA, 1% NP-40, 0.4% deoxycholate) and used for analysis of protein expression by Western blot.
RT-PCR and nucleotide sequencing
RNA was isolated from preextinction populations of passages in the presence of FU (P2) or Rib (P1), and untreated controls (P5). RNA samples were subjected to RT-PCR to amplify genomic regions corresponding to three different LCMV genes: NP, GP and L. Reverse transcription of RNA to cDNA was performed using Superscript II RT, starting with 1 g of RNA and using random hexamers as primers. Amplification of cDNA was performed using Taq polymerase (Boehringer Mannheim) as specified by the manufacture and the appropriate LCMV specific primers to amplify coding regions comprising the following amino acids of GP, NP, and L: 59 to 227 (GP), 190 to 360 (NP) and 2040 to 2210 (L). The sequence of oligonucleotides, primers, and specific PCR conditions used are available from the authors upon request. RT-PCR products were fractionated by agarose gel electrophoresis and fragments with the predicted sizes purified and cloned. DNA sequencing was done with an ABI 373 automatic sequencer.
